Skip to main content
PTGX logo

Protagonist Therapeutics, Inc.

PTGXNASDAQHealthcareBiotechnology

$138.43Today:- (-)1Y +88.59%

As of Oct 23, 2026 close

Market cap
$9.83B
P/E (TTM)
118.56
Forward P/E
70.99
Dividend yield
-
52-week range
$73.08$160.81
Volume (live)
-
Avg. volume (3M)
799.77K

Protagonist Therapeutics, Inc. (PTGX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Protagonist Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 14 professional research analysts

Consensus Rating

Buy
Based on 14 unique analysts
(21 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$174.58
+26.11% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PTGX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Tara Bancroft
TD Cowen
BuyReiterates
$155.00 → $160.00
Geoff Meacham
Citi
BuyMaintains
$182.00
Etzer Darout
Barclays
BuyMaintains
$180.00
Unknown Analyst
Leerink Partners
BuyReiterates
$150.00 → $190.00
Alice Nettleton
UBS
BuyInitiates
$184.00
Geoff Meacham
Citi
BuyMaintains
$175.00 → $182.00
Kaveri Pohlman
Clear Street
BuyMaintains
$173.00
Douglas Tsao
HC Wainwright
BuyInitiates Coverage
$167.00 → $170.00
Srikripa Devarakonda
Truist
BuyMaintains
-
Richard Law CFA
Goldman Sachs
BuyMaintains
$186.00
Etzer Darout
Barclays
BuyMaintains
$153.00 → $180.00
Brian Cheng
JP Morgan
BuyReiterates
$149.00
Kaveri Pohlman
Clear Street
BuyMaintains
$173.00
Jonathan Wolleben
Citizens JMP
BuyMaintains
$165.00 → $170.00
Yun Zhong
Wedbush
BuyMaintains
$173.00
Douglas Tsao
HC Wainwright
BuyReiterates
$167.00 → $170.00
Richard Law CFA
Goldman Sachs
BuyMaintains
$186.00
Brian Cheng
JP Morgan
BuyReiterates
$149.00
Evan Seigerman
BMO Capital
BuyMaintains
$178.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Tara Bancroft
TD Cowen
BuyMaintains
$155.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for PTGX?

The analyst consensus rating for PTGX is Buy, based on the latest ratings from 14 analysts over the last 90 days.

What is the average price target for PTGX?

The average 12-month price target for PTGX is $174.58, representing an upside of 26.1% from the Oct 23, 2026 close of $138.43.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.